SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome

MK Kashyap, HC Harsha, S Renuse… - Cancer biology & …, 2010 - Taylor & Francis
The identification of secreted proteins that are differentially expressed between non-
neoplastic and esophageal squamous cell carcinoma (ESCC) cells can provide potential …

[HTML][HTML] Lysosomes, curcumin, and anti-tumor effects: how are they linked?

Q Shen, X Pan, Y Li, J Li, C Zhang, X Jiang… - Frontiers in …, 2023 - frontiersin.org
Curcumin is a natural active ingredient from traditional Chinese medicine (TCM) that has
multi-target characteristics to exert extensive pharmacological activities and thus has been …

Prognostic role of high cathepsin D expression in breast cancer: a systematic review and meta-analysis

J Kang, Y Yu, S Jeong, H Lee, HJ Heo… - … in medical oncology, 2020 - journals.sagepub.com
Background: High cathepsin D has been associated with poor prognosis in breast cancer;
however, the results of many studies are controversial. Here, we assessed the association …

Cathepsin D inhibits oxidative stress-induced cell death via activation of autophagy in cancer cells

YS Hah, HS Noh, JH Ha, JS Ahn, JR Hahm, HY Cho… - Cancer letters, 2012 - Elsevier
Cathepsin D (CatD), a lysosomal aspartic protease, plays an essential role in tumor
progression and apoptosis. However, the function of CatD in cell death is not yet fully …

A proteomic analysis during serial subculture and osteogenic differentiation of human mesenchymal stem cell

HJ Sun, YY Bahk, YR Choi, JH Shim… - Journal of …, 2006 - Wiley Online Library
Although previous studies have reported the effects of extensive subculturing on
proliferation rates and osteogenic potential of human mesenchymal stem cells (hMSCs), the …

[HTML][HTML] Cathepsin-D, a key protease in breast cancer, is up-regulated in obese mouse and human adipose tissue, and controls adipogenesis

O Masson, C Prébois, D Derocq, A Meulle, C Dray… - Plos one, 2011 - journals.plos.org
The aspartic protease cathepsin-D (cath-D) is overexpressed by human epithelial breast
cancer cells and is closely correlated with poor prognosis in breast cancer. The adipocyte is …

[HTML][HTML] Graphene oxide-based targeting of extracellular cathepsin D and cathepsin L as a novel anti-metastatic enzyme cancer therapy

TA Tabish, MZI Pranjol, DW Horsell, AAM Rahat… - Cancers, 2019 - mdpi.com
Overexpression and secretion of the enzymes cathepsin D (CathD) and cathepsin L (CathL)
is associated with metastasis in several human cancers. As a superfamily, extracellularly …

Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1

L Chen, H Li, W Liu, J Zhu, X Zhao, E Wright… - …, 2011 - academic.oup.com
The human olfactomedin 4 gene (OLFM4) encodes an olfactomedin-related glycoprotein.
OLFM4 is normally expressed in a limited number of tissues, including the prostate, but its …

Type 2 diabetes alters mesenchymal stem cell secretome composition and angiogenic properties

J Ribot, G Caliaperoumal, J Paquet… - Journal of Cellular …, 2017 - Wiley Online Library
This study aimed at characterizing the impact of type 2 diabetes mellitus (T2 DM) on the
bone marrow mesenchymal stem cell (BMMSC) secretome and angiogenic properties …

The propeptide of cathepsin D increases proliferation, invasion and metastasis of breast cancer cells

SS Ohri, A Vashishta, M Proctor… - International …, 2008 - spandidos-publications.com
Expression and secretion of procathepsin D (pCD) increases proliferation, metastasis and
progression of breast cancer but the structural moiety by which pCD exerts these effects is …